PURPOSE:Human centrifugation, also called artificial gravity (AG), is proposed as a combined strategy against detrimental effects of microgravity in long-term space missions. This study scrutinized human short-arm centrifugation as countermeasure against musculoskeletal de-conditioning. METHOD:Eleven healthy male subjects [mean age of 34 (SD 7) years] completed the cross-over trial, including three campaigns of -6° head-down tilt bed rest (HDT) for 5 days, with preceding baseline data collection and recovery phases. Bed rest without AG was used as control condition (Ctrl), and AG with 1 g at the center of mass applied once per day for 30 min in one bout (AG1×30) and in 6 bouts of 5 min (AG6×5, 3-min rest between bouts) as experimental conditions. End-points were muscle strength, vertical jump performance, and biomarkers of bone and protein metabolism. RESULT: AG6×5 was better tolerated than AG1×30. Bone resorption markers CTX, NTX, and DPD all increased by approximately 25 % toward the end of bed rest (P < 0.001), and nitrogen balance decreased by approximately 3 g/day (P < 0.001), without any protection by AG (P > 0.4). Decreases in vertical jump height by 2.1 (SE 0.6) cm after Ctrl bed rest was prevented by either of the AG protocols (P = 0.039). CONCLUSION: The present study yielded succinct catabolic effects upon muscle and bone metabolism that were un-prevented by AG. The preservation of vertical jump performance by AG in this study is likely caused by central nervous rather than by peripheral musculoskeletal effects.
RCT Entities:
PURPOSE:Human centrifugation, also called artificial gravity (AG), is proposed as a combined strategy against detrimental effects of microgravity in long-term space missions. This study scrutinized human short-arm centrifugation as countermeasure against musculoskeletal de-conditioning. METHOD: Eleven healthy male subjects [mean age of 34 (SD 7) years] completed the cross-over trial, including three campaigns of -6° head-down tilt bed rest (HDT) for 5 days, with preceding baseline data collection and recovery phases. Bed rest without AG was used as control condition (Ctrl), and AG with 1 g at the center of mass applied once per day for 30 min in one bout (AG1×30) and in 6 bouts of 5 min (AG6×5, 3-min rest between bouts) as experimental conditions. End-points were muscle strength, vertical jump performance, and biomarkers of bone and protein metabolism. RESULT: AG6×5 was better tolerated than AG1×30. Bone resorption markers CTX, NTX, and DPD all increased by approximately 25 % toward the end of bed rest (P < 0.001), and nitrogen balance decreased by approximately 3 g/day (P < 0.001), without any protection by AG (P > 0.4). Decreases in vertical jump height by 2.1 (SE 0.6) cm after Ctrl bed rest was prevented by either of the AG protocols (P = 0.039). CONCLUSION: The present study yielded succinct catabolic effects upon muscle and bone metabolism that were un-prevented by AG. The preservation of vertical jump performance by AG in this study is likely caused by central nervous rather than by peripheral musculoskeletal effects.
Authors: Jörn Rittweger; Gisela Beller; Gabriele Armbrecht; Edwin Mulder; Björn Buehring; Ulf Gast; Fernando Dimeo; Harald Schubert; Arnold de Haan; Dick F Stegeman; Hans Schiessl; Dieter Felsenberg Journal: Bone Date: 2009-09-02 Impact factor: 4.398
Authors: C Capelli; G Antonutto; M Azabji Kenfack; M Cautero; F Lador; C Moia; E Tam; G Ferretti Journal: Eur J Appl Physiol Date: 2006-08-19 Impact factor: 3.078
Authors: Jörn Rittweger; Bostjan Simunic; Giancarlo Bilancio; Natale Gaspare De Santo; Massimo Cirillo; Gianni Biolo; Rado Pisot; Ola Eiken; Igor B Mekjavic; Marco Narici Journal: Bone Date: 2009-01-09 Impact factor: 4.398
Authors: Andreas Kramer; María Venegas-Carro; Edwin Mulder; Jessica K Lee; María Moreno-Villanueva; Alexander Bürkle; Markus Gruber Journal: Front Physiol Date: 2020-09-11 Impact factor: 4.566
Authors: Gian C Demontis; Marco M Germani; Enrico G Caiani; Ivana Barravecchia; Claudio Passino; Debora Angeloni Journal: Front Physiol Date: 2017-08-02 Impact factor: 4.566
Authors: J Buehlmeier; P Frings-Meuthen; N Mohorko; P Lau; S Mazzucco; J L Ferretti; G Biolo; R Pisot; B Simunic; J Rittweger Journal: J Musculoskelet Neuronal Interact Date: 2017-03-01 Impact factor: 2.041
Authors: Robert Ekman; David A Green; Jonathon P R Scott; Roger Huerta Lluch; Tobias Weber; Nolan Herssens Journal: Front Physiol Date: 2022-07-04 Impact factor: 4.755
Authors: G Clément; W H Paloski; J Rittweger; D Linnarsson; M P Bareille; E Mulder; F L Wuyts; J Zange Journal: J Musculoskelet Neuronal Interact Date: 2016-06-07 Impact factor: 2.041